ArticleNeurology and therapy2020

Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years.

Giampaolo Merlini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.